Argent Biopharma Limited Company Presentation
01 Julho 2024 - 3:02AM
RNS Regulatory News
RNS Number : 5463U
Argent Biopharma Limited
01 July 2024
1
July 2024
Argent BioPharma
Ltd.
(Argent BioPharma or the Company)
Company
Presentation
Argent BioPharma, an innovative
multidisciplinary drug discovery company within the
biopharmaceutical sector, announces the publication of its Company
Presentation for June 2024 which may be accessed via the following
link:
https://www.investi.com.au/api/announcements/rgt/ed231bfb-b84.pdf
-Ends-
Authorised for release by the board of directors, for further
information please contact:
About Argent
BioPharma
Argent BioPharma Limited (the
"Company") (ASX: RGT; LSE: RGT; ORCQB: RGTLF) is a Clinical-Stage,
Revenue Generating Biopharmaceutical Company committed to providing
accessible medical treatments for unmet medical needs, to bridge
the gap where medical solutions currently fall short. The
Group focuses on the Multidisciplinary method with Nanotechnology,
developing multi-target therapies for comprehensive disease
management, especially concerning to the
Central nervous system ("CNS") and Immunology treatments.
Follow us through our social media channels:
LinkedIn: Argent
BioPharma
Twitter: @ArgentBioPharma
Facebook: Argent BioPharma
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
MSCRBMATMTAMMII
Argent Biopharma (LSE:RGT)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Argent Biopharma (LSE:RGT)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
